PTEN and breast carcinoma: Loss of PTEN (phosphatase and tensin homolog), a negative regulator of PI3K-Akt signaling, has been detected in 25% to 71% of brain metastases in breast cancer patients and occurs preferentially in TNBC [34, 35, 41].